Original Report

Impact of surgery for stage IA non-small-cell lung cancer on patient quality of life


 

Background There is a paucity of literature comparing quality of life (QoL) before and after surgery in stage IA lung cancer, where surgical resection is the recommended curative treatment.

Objective To assess the impact of surgery on physical and mental health-related QoL in patients with stage IA lung cancer treated with surgical resection.

Methods Participants in the I-ELCAP cohort who were diagnosed with their first primary pathologic stage IA non-small-cell lung cancer, underwent surgery, and provided follow-up information on QoL 1 year later were included in the present analysis (N = 107). QoL information was collected using the SF-12 (12-item Short Form Health Survey), which generates 2 component scores related to mental health and physical health.

Results Statistical analyses indicated that physical health QoL was significantly worsened from before surgery to after surgery, whereas mental health QoL marginally improved from before to after surgery. Physical health QoL worsened for women from baseline to follow-up, but not for men. Only lobectomy (not limited resection) had an impact on QoL from before to after surgery.

Limitations Results are considered preliminary given the small sample size and multiple comparisons.

Conclusions The current study findings have implications for lung cancer health care professionals in regard to how they can most effectively present the possible impact of surgery on quality of life to this subset of patients in which disease has not yet significantly progressed.

Funding/sponsorship Gift from Sonia Lasry Gardner, in memory of her father, Moise Lasry.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Late risks of breast cancer RT are higher for smokers
MDedge Hematology and Oncology
Families perceive few benefits from aggressive end-of-life care
MDedge Hematology and Oncology
Adjuvant therapy extends survival in early SCLC
MDedge Hematology and Oncology
Deciphering lung cancer biomarkers shrouded in tobacco smoke
MDedge Hematology and Oncology
Presurgery radiation shows benefit in lung cancer
MDedge Hematology and Oncology
Research refining radiomic features for lung cancer screening
MDedge Hematology and Oncology
PROCLAIM: Pemetrexed combo no better than standard tx in NSCLC
MDedge Hematology and Oncology
VIDEO: Which lesions are best for bronchoscopic endoluminal treatment?
MDedge Hematology and Oncology
STS: Hybrid thoracic suite leverages CT’s imaging sensitivity
MDedge Hematology and Oncology
VIDEO: Novel imaging technique helps hunt for pulmonary lesions
MDedge Hematology and Oncology